Health
BioNTech/Pfizer Vaccination Analysis Confirms High Overall Efficacy – Clinical OMICs News
Results from an analysis of COVID-19 vaccination data from Israel show over 90% protection from SARS-CoV-2 infection with the BioNTech/Pfizer vaccine. However,…
Results from an analysis of COVID-19 vaccination data from Israel, where most of the population have now been vaccinated, confirm earlier Phase III data and show over 90% protection from asymptomatic and symptomatic disease with the BioNTech/Pfizer vaccine.
Notably, this efficacy held true despite several variants of concern circulating in Israel at the time of vaccination, with the UK B.1.1.7 variant being the most common. While efficacy was good, there was a decrease in efficacy in much older…
-
Business22 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News17 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Noosa News24 hours agoBarry Du Bois opens up at the high-tech Hinterland Health Retreat
-
Business24 hours agoWhat’s Bell Potter’s take on Endeavour Group shares following earnings results?